• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

COMPASS Pathways Plc (CMPS)

American Depository Receipt
Sell: $5.60|Buy: $5.69|Change: 0.09 (1.63%)

This share can be held in a Dealing accountSIPP

Company profile

Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The company is conducting clinical trials to evaluate the safety and efficacy of this treatment in patients with treatment-resistant depression and other mental health disorders. The company operates in one operating segment.

Address

3rd Floor, 1 Ashley Road
Altrincham
Cheshire
GBR
WA14 2DT

Website

https://compasspathways.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Compass Pathways PLC Fourth Quarter Earnings Results for 20262027-03-24T00:00:00
Compass Pathways PLC Annual Report for 20262027-03-24T00:00:00
Compass Pathways PLC Third Quarter Earnings Conference Call for 20262026-11-04T08:00:00
Compass Pathways PLC Third Quarter Earnings Results for 20262026-11-04T00:00:00
Compass Pathways PLC Second Quarter Earnings Conference Call for 20262026-07-31T08:00:00
Compass Pathways PLC Second Quarter Earnings Results for 20262026-07-31T00:00:00
Compass Pathways PLC Annual General Meeting for 20262026-06-12T08:30:00
Compass Pathways PLC First Quarter Earnings Conference Call for 20262026-05-08T08:00:00
Compass Pathways PLC First Quarter Earnings Results for 20262026-05-08T00:00:00

Previous key dates

NameKey Date
Compass Pathways PLC Fourth Quarter Earnings Conference Call for 20252026-03-27T08:00:00
Compass Pathways PLC Fourth Quarter Earnings Results for 20252026-03-24T00:00:00
Compass Pathways PLC Annual Report for 20252026-03-24T00:00:00
Stifel 2026 Virtual CNS Forum2026-03-18T10:30:00
TD Cowen 46th Annual Healthcare Conference2026-03-03T10:30:00
Piper Sandler 37th Annual Healthcare Conference2025-12-03T13:30:00
8th Annual Evercore Healthcare Conference2025-12-02T10:00:00
Stifel 2025 Healthcare Conference2025-11-11T10:40:00
Compass Pathways PLC Third Quarter Earnings Conference Call for 20252025-11-04T08:00:00
Compass Pathways PLC Third Quarter Earnings Results for 20252025-11-04T00:00:00
TD Cowen’s 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit2025-09-17T10:40:00
Morgan Stanley 23rd Annual Global Healthcare Conference2025-09-09T10:45:00
H.C. Wainwright 27th Annual Global Investment Conference2025-09-09T09:00:00
Cantor Global Healthcare Conference2025-09-03T13:35:00
Canaccord Genuity 45th Annual Growth Conference2025-08-12T16:00:00
Compass Pathways PLC Second Quarter Earnings Conference Call for 20252025-07-31T08:00:00
Compass Pathways PLC Second Quarter Earnings Results for 20252025-07-31T00:00:00
Compass Pathways PLC Annual General Meeting for 20252025-06-12T08:30:00
2025 RBC Capital Markets Global Healthcare Conference2025-05-20T10:30:00
Compass Pathways PLC First Quarter Earnings Conference Call for 20252025-05-08T08:00:00
Compass Pathways PLC First Quarter Earnings Result for 20252025-05-08T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.